Get access to our best features
Get access to our best features
Published

Bioptimus nabs $41m to develop 'ChatGPT for biology'

  • A French AI startup, Bioptimus, has raised $41 million to develop a foundational AI model for biology, bringing its total funding to $76 million since its founding last year.
  • The funding round was led by U.S. Venture capital firm Cathay Innovation, with participation from several other investors.
  • Bioptimus launched H-Optimus-0, an open source foundation model for pathology, aimed at improving disease research and diagnosis.
  • CEO Jean-Philippe Vert stated that the goal is to simulate biology to predict disease outcomes and develop effective treatments.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)